I agree that this site is using cookies. You can find further informations here.
X
Friedlaender, Alex
203  results:
Search for persons X
?
1

Management of stage III non-small-cell lung cancer: rays of..:

Kim, Floryane ; Borgeaud, Maxime ; Addeo, Alfredo.
Exploration of Targeted Anti-tumor Therapy.  5 (2024)  1 - p. 85-95 , 2024
Link: https://doi.org/10.37349..
 
?
2

Oncogenic alterations in advanced NSCLC: a molecular super-..:

Friedlaender, Alex ; Perol, Maurice ; Banna, Giuseppe Luigi..
Biomarker Research.  12 (2024)  1 - p. , 2024
Link: https://doi.org/10.1186/..
 
?
3

Editorial: Molecular characterization of thyroid lesions in..:

Malapelle, Umberto ; Bellevicine, Claudio ; Friedlaender, Alex..
Frontiers in Endocrinology.  15 (2024)  - p. , 2024
Link: https://doi.org/10.3389/..
 
?
4

Precision Oncology in Gastrointestinal Stromal Tumors:

Mechahougui, Hiba ; Michael, Montemurro ; Friedlaender, Alex
Current Oncology.  30 (2023)  5 - p. 4648-4662 , 2023
Link: https://doi.org/10.3390/..
 
?
5

Current Approaches to Neoadjuvant Immunotherapy in Resectab..:

Parekh, Jay ; Parikh, Kaushal ; Reuss, Joshua E...
Current Oncology Reports.  25 (2023)  8 - p. 913-922 , 2023
Link: https://doi.org/10.1007/..
 
?
6

The Evolving Role of Immune-Checkpoint Inhibitors in Malign..:

Borgeaud, Maxime ; Kim, Floryane ; Friedlaender, Alex...
Journal of Clinical Medicine.  12 (2023)  5 - p. 1757 , 2023
Link: https://doi.org/10.3390/..
 
?
7

Neoadjuvant Immunotherapy: A Promising New Standard of Care:

Boydell, Emma ; Sandoval, Jose L. ; Michielin, Olivier...
International Journal of Molecular Sciences.  24 (2023)  14 - p. 11849 , 2023
Link: https://doi.org/10.3390/..
 
?
8

Unraveling the Nexus: Oncogenic Drivers and Immunotherapy E..:

Mechahougui, Hiba ; Friedlaender, Alex
Immunotherapy.  16 (2023)  5 - p. 267-271 , 2023
Link: https://doi.org/10.2217/..
 
?
9

Cellular Therapy in NSCLC: Between Myth and Reality:

Imbimbo, Martina ; Wetterwald, Laureline ; Friedlaender, Alex..
Current Oncology Reports.  25 (2023)  10 - p. 1161-1174 , 2023
Link: https://doi.org/10.1007/..
 
?
10

Evolution of biological features of invasive lobular breast..:

Trillo, Pamela ; Sandoval, Josè ; Trapani, Dario...
European Journal of Cancer.  185 (2023)  - p. 119-130 , 2023
Link: https://doi.org/10.1016/..
 
?
11

Hematologic toxicities of chemotherapy in breast and ovaria..:

Hu-Heimgartner, Ketty ; Lang, Noémie ; Ayme, Aurélie...
Familial Cancer.  22 (2023)  3 - p. 283-289 , 2023
Link: https://doi.org/10.1007/..
 
?
12

RET aberrant cancers and RET inhibitor therapies: Current s..:

Addeo, Alfredo ; Miranda-Morales, Ernesto ; den Hollander, Petra...
Pharmacology & Therapeutics.  242 (2023)  - p. 108344 , 2023
Link: https://doi.org/10.1016/..
 
?
13

Pleural Mesothelioma in the Era of Immunotherapy:

Chevallier, Mathieu ; Kim, Floryane ; Friedlaender, Alex.
Clinical Medicine Insights: Oncology.  17 (2023)  - p. , 2023
Link: https://doi.org/10.1177/..
 
?
14

Aktuelle Ansätze zur neoadjuvanten Immuntherapie des resekt..:

Parekh, Jay ; Parikh, Kaushal ; Reuss, Joshua E...
Kompass Pneumologie.  11 (2023)  6 - p. 287-295 , 2023
Link: https://doi.org/10.1159/..
 
?
15

Evolving Therapeutic Scenario of Stage III Non-Small-Cell L..:

Baudoux, Nathalie ; Friedlaender, Alex ; Addeo, Alfredo
Clinical Medicine Insights: Oncology.  17 (2023)  - p. 117955492311529 , 2023
Link: https://doi.org/10.1177/..
 
1-15